Page 36 - பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா டேவிஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

email article A new combined hormonal contraceptive pill was found to be effective across a wide range of patients, according to data from a phase III trial. Estetrol/drospirenone (Nextstellis) had high contraceptive efficacy regardless of age group, body mass index (BMI), or prior contraceptive use, reported Mitchell Creinin, MD, of the University of California Davis in Sacramento. Additionally, unscheduled bleeding occurred in less than a quarter of women, and decreased over time, he said in a presentation at the American College of Obstetricians and Gynecologists (ACOG) virtual meeting. Estetrol (E4) is a native estrogen produced by the human fetal liver. Its unique characteristics result in selective activity in tissue, and in combination with drospirenone, it suppresses ovulation while having minimal impact on hormone-binding globulins, lipids, endocrine parameters, and hemostatic parameters.

United statesUniversity of california davisMitchell creininAmanda dambrosioAmerican college of obstetriciansCalifornia davisAmerican collegePearl indexMedpage todayஒன்றுபட்டது மாநிலங்களில்பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா டேவிஸ்அமண்டா டம்பிரோசியோஅமெரிக்கன் கல்லூரி ஆஃப் மகப்பேறியல்கலிஃபோர்னியா டேவிஸ்அமெரிக்கன் கல்லூரிமுத்து குறியீட்டு